Equities

Krynica Vitamin SA

0RDK:LSE

Krynica Vitamin SA

Actions
  • Price (PLN)0.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Dec 30 1899.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Krynica Vitamin SA is a Poland-based company engaged in the beverages industry. The Company is a producer of non-alcoholic and low-alcoholic beverages. It specializes in producing beverages for its own brands and providing bottling services for brand-name products. The Company's offer includes functional and energy drinks, such as isotonic and hypotonic drinks, beverages that support the metabolism, and vitamin dietary supplements. Krynica Vitamin SA also provides functional waters, modern mixed-fruit drinks, drinks with fruit pulp, alcopops, ciders, malt beverages and a selection of carbonated beverages. In addition, the Company is engaged in the research and development services for its products. It operates through Dent Blanche s r o.

  • Revenue in PLN (TTM)359.23m
  • Net income in PLN-6.68m
  • Incorporated2011
  • Employees336.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.